Cell and Gene Therapy Market Size, Share & Industry Analysis by Type (Cell Therapy {Therapy Type [CAR-T Cell Therapy, TCR-T Cell Therapy, Natural Killer (NK) Cells, and Others], Product Type [Kymriah, Yescarta, Tecartus, Breyanzi, Abecma, Carvykti, and Others], Indication [Oncology and Others]} and Gene Therapy {Product Type [Zolgensma, Luxturna, Roctavian, and Others], Vector Type [Viral Vectors and Non-Viral Vectors], Indication [Genetic Disorders, Ophthalmology, Hematology, and Others]}), By End User (Hospitals & Clinics, Specialty Clinics, and Others), and Regional Forecast, 2026-2034
Last Updated: January 26, 2026
| Format: PDF
| Report ID: FBI114130